Phase II Pilot Study of Vincristine, Adriamycin, Actinomycin D, Ifosfamide Combination Chemotherapy in Ewing's Sarcoma

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00541411

Enrollment

Registered

2007-10-10

Start date

2003-06-30

Completion date

2013-06-30

Last updated

2012-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ewing's Sarcoma

Brief summary

Phase II Pilot Study of Vincristine, Adriamycin, Actinomycin D, Ifosfamide combination chemotherapy in Ewing's Sarcoma

Interventions

DRUGVincristine, Actinomycin-D, Ifosfamide

Chemotherapy

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Patients with Ewing's Sarcoma

Design outcomes

Primary

Measure	Time frame
Efficacy	overall

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026